Please provide your email address to receive an email when new articles are posted on . 47.5% of patients treated with glucocorticoids reported myopathy. Cumulative dosage, age, sex and weight were ...
Everyday Health on MSN
What’s next in obstructive hypertrophic cardiomyopathy treatment?
From next-generation medications to groundbreaking gene therapies and nonsurgical procedures, explore the pipeline of ...
Findings from a study supported in part by the National Institutes of Health (NIH) have identified a new model for predicting ...
Topline results announced today show gains in KCCQ and peak oxygen consumption—the full dataset is coming soon.
(Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of wild-type or hereditary ...
Cardiomyopathy can be a diverse diagnosis. There are many different types -- some inherited, others due to injury to the heart, treatment side effects, pregnancy, and a range of other causes. The ...
Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes. Researchers at the University of Oxford, in collaboration with other researchers, ...
Please provide your email address to receive an email when new articles are posted on . Black patients with hypertrophic cardiomyopathy were often diagnosed at a younger age and were less likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results